Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure.

导出 LinkOut

翻译打印收藏纠错

作者： Krisha K,Mehta ^[1] ; Rosa,Nouvini ^[2] ; Jingxuan,Liu ^[3] ; Yi,Wang ^[3] ; Alison,Stopeck ^[4]

作者单位： Department of Medicine, Stony Brook University, Stony Brook, NY, United States. ^[1] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. ^[2] Department of Pathology, Stony Brook University, Stony Brook, NY, United States. ^[3] Department of Medicine, Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States. ^[4]

关键词 breast cancer with choriocarcinomatous features chemotherapy choriocarcinoma long term remission metaplastic breast cancer methrotrexate

DOI 10.3389/fonc.2022.1061679

PMID 36686740

发布时间 2023-03-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

1061679页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Case report: Metastatic metaplastic breast cancer with choriocarinomatous features: Targeting the choriocarcinoma component for cure.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除